NCT06964269View on ClinicalTrials.gov

Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

February 28, 2028

Study Completion Date

February 28, 2028

Conditions
Autoimmune DiseasesDry EyeNeurotrophic Keratitis
Interventions
DRUG

Acthar Gel 80 UNT/ML Injectable Solution

Study intervention is twice weekly injections of Acthar Gel via single-dose pre-filled SelfJect injector for 12 weeks.

Trial Locations (1)

37215

RECRUITING

Toyos Clinic, Nashville

All Listed Sponsors
lead

Toyos Clinic

OTHER